Shoulder InnovationsFRA:VB3 +8.72%18 Receivables Turnover is 1.79 as of Mar. 2026. GuruFocus rates FRA:VB3 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Shoulder Innovations ranks better than 66.67% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shoulder Innovations's Revenue for the
three
months ended in Mar. 2026 was €14.45 Mil. Shoulder Innovations's average Accounts Receivable for the
three
months ended in Mar. 2026 was €8.09 Mil.
Hence, Shoulder Innovations's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.79.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Shoulder Innovations Receivables Turnover Related Terms
Shoulder Innovations Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Shoulder Innovations's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VB3 vs ELMD, MASS, CV: Receivables Turnover Comparison
For the Medical Devices subindustry, Shoulder Innovations's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shoulder Innovations Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Shoulder Innovations's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shoulder Innovations (FRA:VB3) has a Receivables Turnover of 1.79 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shoulder Innovations and its competitors. According to the industry distribution chart, Shoulder Innovations ranks #271 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is Shoulder Innovations' Receivables Turnover too high?
Shoulder Innovations' current Receivables Turnover is 1.79. The Medical Devices & Instruments industry median Receivables Turnover is 5.58. Shoulder Innovations' value of 1.79 is 67.9% below this industry median. Based on the distribution chart, Shoulder Innovations ranks #271 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shoulder Innovations has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' Receivables Turnover compare to ELMD and MASS?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #271 out of 813 companies for Receivables Turnover. This puts Shoulder Innovations in the upper half of its industry. The industry median Receivables Turnover is 5.58. Shoulder Innovations' value of 1.79 is 67.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.58, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shoulder Innovations's current Receivables Turnover of 1.79 is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current Receivables Turnover is 1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current Receivables Turnover of 1.79. The current Receivables Turnover is 1.79 and 67.9% below the Medical Devices & Instruments industry median of 5.58. Shoulder Innovations' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current Receivables Turnover is 1.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
18GF Score
Get the complete analysis for FRA:VB3
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB3 has been successfully added to your 
